Welcome to medications.com

Competitive Advantages Position GlaxoSmithKline's Novel ... - PR Newswire (press release)

... a benign prostatic hyperplasia drug treatment with a lower incidence of sexual side effects than that of tamsulosin (Boehringer Ingelheim's Flomax, ...

Posted: Tue Feb 26 09:05:47 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com